Boulding Mark Elliott bought PTCT
January 7, 2026 · Form 4 insider transaction
Boulding Mark Elliott bought 2,625 shares of PTC Therapeutics, Inc. at $38.10 per share, a transaction worth $100.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,625
Price
$38.10
Total value
$100.0K
InsiderBoulding Mark Elliott
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 7, 2026
Filing dateJanuary 8, 2026
Shares owned after120,284
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.